HTGC 📈 Hercules Capital - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4270965084
HTGC: Venture Debt, Growth Capital, Private Equity, Loans, Financing
Hercules Capital, Inc. is a business development company that specializes in providing customized financing solutions to privately held venture capital-backed companies across various stages of development, from mid-venture to expansion stage, as well as select publicly listed companies and special opportunity companies.
The firm's financing solutions cater to a wide range of needs, including capital extension, management buy-out and corporate spin-out financing, company, asset-specific, or intellectual property acquisition financing, and more. It offers a variety of loan options, such as convertible, subordinated, and/or mezzanine loans, to support domestic and international corporate expansion, vendor financing, and revenue acceleration.
In addition, Hercules Capital provides asset-based financing solutions, focusing on cash flow, accounts receivable facilities, equipment loans or leases, and working capital revolving lines of credit. The firm also offers bridge financing for initial public offerings (IPOs), mergers and acquisitions, technology acquisitions, and dividend recapitalizations, as well as cash flow financing to protect against share price volatility.
The firm's investment strategy involves investing primarily in structured debt with warrants, and to a lesser extent, in senior debt and equity investments. Hercules Capital typically seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment, with a focus on technology, SaaS finance, energy technology, and sustainable industries.
By providing flexible and tailored financing solutions, Hercules Capital aims to support the growth and development of its portfolio companies, enabling them to achieve their strategic objectives and drive long-term success.
For more information, please visit Hercules Capital's website at https://www.htgc.com.
Additional Sources for HTGC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HTGC Stock Overview
Market Cap in USD | 3,048m |
Sector | Financial Services |
Industry | Asset Management |
GiC Industry | Capital Markets |
TER | 0.00% |
IPO / Inception | 2005-06-09 |
HTGC Stock Ratings
Growth 5y | 81.7% |
Fundamental | 57.6% |
Dividend | 90.0% |
Rel. Performance Sector | -5.32 |
Analysts | 3.89/5 |
Fair Price Momentum | 21.37 USD |
Fair Price DCF | 5.81 USD |
HTGC Dividends
Dividend Yield 12m | 8.46% |
Yield on Cost 5y | 19.23% |
Annual Growth 5y | 7.39% |
Payout Consistency | 91.29% |
HTGC Growth Ratios
Growth Correlation 3m | -15.1% |
Growth Correlation 12m | 81.3% |
Growth Correlation 5y | 87% |
CAGR 5y | 17.83% |
CAGR/Mean DD 5y | 1.66 |
Sharpe Ratio 12m | 1.26 |
Alpha | -6.59 |
Beta | 1.22 |
Volatility | 19.06% |
Current Volume | 749.7k |
Average Volume 20d | 1146k |
As of December 07, 2024, the stock is trading at USD 18.91 with a total of 749,700 shares traded.
Over the past week, the price has changed by -0.11%, over one month by +0.89%, over three months by +1.79% and over the past year by +35.13%.
Partly, yes. Based on ValueRay Fundamental Analyses, Hercules Capital (NYSE:HTGC) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.60 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HTGC as of December 2024 is 21.37. This means that HTGC is currently undervalued and has a potential upside of +13.01% (Margin of Safety).
Hercules Capital has received a consensus analysts rating of 3.89. Therefor, it is recommend to buy HTGC.
- Strong Buy: 3
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, HTGC Hercules Capital will be worth about 23.9 in December 2025. The stock is currently trading at 18.91. This means that the stock has a potential upside of +26.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 20.6 | 9.1% |
Analysts Target Price | 17.7 | -6.5% |
ValueRay Target Price | 23.9 | 26.5% |